Prothena Corporation plc PRTA
8.43 USD -0.30 (-3.44%)
Nov 12, 2026, 10:08 AM EST
8.41 Day range 8.70
7.89 52-week range 11.51
- YTD
- -11.73%
- 1 year
- -22.30%
Benzinga news
benzinga.com CORRECTION: Prothena Corp Q2 EPS $(0.36) Misses $(0.09) Estimate, Sales $1.010M Miss $28.295M Estimate Prothena Corp (NASDAQ:PRTA) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.09) by 300 percent. This is a 79.19 percent increase over losses of…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Jupiter Neurosciences (NASDAQ:JUNS) stock rose 36.4% to $0.23 during Tuesday's pre-market session. The market value of their outstanding shares is at $7.9 million. Imunon (NASDAQ:IMNN) shares…
benzinga.com Why Crown Holdings Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket Crown Holdings Inc (CCK) stock gained 16.4% in pre-market trading after reporting strong Q2 results and raising its FY26 EPS guidance. Other gaining stocks include SLGB, HIHO, WNW, CHNR, RDGT, ULBI,…
benzinga.com UPDATED: Watching Prothena; Shares Spike Higher, Form4 Filing Shows William P. Scully Bought 100,000 Shares At An Average Price Of $9.81/Share https://www.sec.gov/Archives/edgar/data/1559053/000104546326000004/xslF345X06/primary_doc.xml
benzinga.com Citizens Maintains Market Outperform on Prothena Corp, Raises Price Target to $20 Citizens analyst Jason N. Butler maintains Prothena Corp (NASDAQ:PRTA) with a Market Outperform and raises the price target from $19 to $20.
benzinga.com Prothena Corp Q1 EPS $0.60 Beats $(0.34) Estimate, Sales $51.084M Beat $1.010M Estimate Prothena Corp (NASDAQ:PRTA) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $(0.34) by 276.47 percent. This is a 153.57 percent increase over losses of…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session 
benzinga.com Prothena Announces Coramitug Amyloid Depleter Antibody Receives FDA's Fast Track Designation To Treat ATTR Amyloidosis With Cardiomyopathy Prothena Corporation plc (NASDAQ:PRTA) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to coramitug, a potential best-in-class amyloid depleter…
benzinga.com RBC Capital Maintains Sector Perform on Prothena Corp, Raises Price Target to $12 RBC Capital analyst Brian Abrahams maintains Prothena Corp (NASDAQ:PRTA) with a Sector Perform and raises the price target from $11 to $12.
benzinga.com Prothena Corp Q4 Earnings Assessment 
benzinga.com Prothena Corp Q4 EPS $(0.40) Beats $(0.54) Estimate, Sales $21.000K Miss $1.334M Estimate Prothena Corp (NASDAQ:PRTA) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.54) by 25.93 percent. This is a 62.96 percent increase over losses of…
benzinga.com Earnings Scheduled For February 19, 2026 
benzinga.com Exploring Prothena Corp's Earnings Expectations 
benzinga.com Amazon To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Monday 
benzinga.com Citizens Maintains Market Outperform on Prothena Corp, Raises Price Target to $19 Citizens analyst Jason Butler maintains Prothena Corp (NASDAQ:PRTA) with a Market Outperform and raises the price target from $11 to $19.
benzinga.com Prothena Data From TDP-43 CYTOPE Program Demonstrates CYTOPE Technology's Potential To Deliver Large Molecules Into Cells Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, announced a…
benzinga.com Novo Nordisk's $100 Million Coramitug Shows Promise In Reducing Heart Failure Biomarker Novo Nordisk's Coramitug cut NT-proBNP levels and was well tolerated in a Phase 2 ATTR-CM trial, paving the way for its Phase 3 CLEOPATTRA study.- benzinga.com Prothena Presents Phase 2 Clinical Study Data For Coramitug For Treatment Of ATTR Amyloidosis With Cardiomyopathy American Heart Association's Circulation Journal Prothena Corporation plc (NASDAQ:PRTA) announced the publication of Phase 2 clinical trial data for coramitug (formerly PRX004), a potential first-in-class amyloid depleter antibody, for the…
- benzinga.com HC Wainwright & Co. Maintains Buy on Prothena Corp, Raises Price Target to $30 HC Wainwright & Co. analyst Andrew S. Fein maintains Prothena Corp (NASDAQ:PRTA) with a Buy and raises the price target from $20 to $30.
benzinga.com Earnings Scheduled For November 6, 2025 
benzinga.com Alibaba To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday - benzinga.com Earnings Scheduled For August 4, 2025
benzinga.com Williams Companies To Rally Over 11%? Here Are 10 Top Analyst Forecasts For Wednesday - benzinga.com 12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com PTC Therapeutics To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Tuesday 
benzinga.com PDD Holdings Posts Weak Results, Joins EHang Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's After-Market Session
- benzinga.com 'FDA Clears First Blood Test Used In Diagnosing Alzheimer's Disease; New Test Provides Less Invasive Option, Reduces Reliance On Pet Scans And Increases Diagnosis Accessibility' - FDA https://www.fda.gov/news-events/press-announcements/fda-clears-first-blood-test-used-diagnosing-alzheimers-disease#:~:text=The%20Lumipulse%20G%20pTau217%2F%C3%9F,and%20symptoms%20of%20the%20disease.
benzinga.com Earnings Scheduled For May 8, 2025 - benzinga.com Earnings Scheduled For February 20, 2025
benzinga.com Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket - benzinga.com This S&P Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
- benzinga.com Earnings Scheduled For November 12, 2024
- benzinga.com Dow Dips 300 Points; Emcore Shares Spike Higher
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
- benzinga.com Crude Oil Moves Higher; Prime Medicine Shares Spike Higher
- benzinga.com Earnings Scheduled For February 15, 2024 Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million.
- benzinga.com Earnings Scheduled For November 2, 2023 Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 369 companies hit new 52-week lows.
- benzinga.com Earnings Scheduled For August 3, 2023 Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
- benzinga.com Earnings Scheduled For May 4, 2023 Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For April 24, 2023
- benzinga.com Earnings Scheduled For February 23, 2023 Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
- benzinga.com Earnings Scheduled For November 3, 2022 Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2022 Upgrades
- benzinga.com Earnings Scheduled For August 8, 2022 Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 951 companies hit new 52-week lows.